Back | Next |
home / stock / avxl / avxl message board
Subject | By | Source | When |
---|---|---|---|
Yes I normally phrase it as approval from | Investor2014 | investorshub | 07/21/2024 10:01:47 PM |
To be perfectly clear YOU are WRONG!!! | georgejjl | investorshub | 07/21/2024 9:39:14 PM |
To be clear, my 1% chance is for | Doc328 | investorshub | 07/21/2024 9:17:48 PM |
They are quite a respected site they don't | Hosai | investorshub | 07/21/2024 8:13:42 PM |
Some posters have complained about Anavex not getting | Steady_T | investorshub | 07/21/2024 8:03:44 PM |
I missed that. That is good news. | Hoskuld | investorshub | 07/21/2024 8:01:02 PM |
This activity is supported by an independent educational | DrJan | investorshub | 07/21/2024 7:52:22 PM |
Do you have some trouble understanding the word possible? | Steady_T | investorshub | 07/21/2024 7:52:12 PM |
It doesn't really matter what our opinions are | Steady_T | investorshub | 07/21/2024 7:48:59 PM |
This is not an Anavex presentation. It | Hoskuld | investorshub | 07/21/2024 7:42:47 PM |
abew: therefore Dr. Missling has figured | nidan7500 | investorshub | 07/21/2024 7:39:15 PM |
Another claim again, complimentary to the Mabs without | DrJan | investorshub | 07/21/2024 7:32:34 PM |
If provides solid support to existing claims and | Investor2014 | investorshub | 07/21/2024 7:11:40 PM |
Itd be fun to see the updated view | Rubyred77 | investorshub | 07/21/2024 7:00:43 PM |
Given our results and recent changes in regulatory | frrol | investorshub | 07/21/2024 6:14:10 PM |
Therefore Dr. Missling has figured out a way | kund | investorshub | 07/21/2024 5:46:14 PM |
Quote: I think that this talking point is | abew4me | investorshub | 07/21/2024 5:35:48 PM |
You and all your friends can Bone up | williamssc | investorshub | 07/21/2024 5:19:06 PM |
Thanks for your consideration. | Hoskuld | investorshub | 07/21/2024 5:13:38 PM |
No-one appears to have asked your chances of | Investor2014 | investorshub | 07/21/2024 5:08:10 PM |
News, Short Squeeze, Breakout and More Instantly...
Anavex Life Sciences Corp. Company Name:
AVXL Stock Symbol:
NASDAQ Market:
Anavex Life Sciences Corp. Website:
Oral, once daily blarcamesine significantly slowed clinical decline for early Alzheimer's disease patients with good comparative safety profile and no associated neuroimaging adverse events Clinical benefit of blarcamesine consistently observed for both 30 mg and 50 mg treatment groups ...
2024-07-18 02:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental and neuropsyc...